Knowledge Palette, Inc. Company Profile

Background

Knowledge Palette, Inc. is a Japanese biotechnology startup founded in 2018, dedicated to revolutionizing drug discovery and regenerative medicine. The company's mission is to create a world where illnesses no longer diminish the smiles of loved ones, aiming to transform healthcare into a beacon of hope.

Key Strategic Focus

Knowledge Palette specializes in phenotypic drug discovery (PDD) and cell manufacturing optimization. By analyzing comprehensive gene expression profiles of cells treated with new drug candidates or culture media, the company addresses challenges in drug development and regenerative medicine. Collaborating with pharmaceutical companies and research institutes, Knowledge Palette applies its platforms to enhance the quality and efficacy of medical treatments.

Financials and Funding

Since its inception, Knowledge Palette has secured multiple funding rounds:

• Seed Round: Raised approximately $1.84 million.

• Series A2: Secured around $4.61 million on March 29, 2021.

• Series B: Obtained $6.33 million on July 18, 2023, with Zeon Corporation as a notable investor.

The capital is intended to advance the company's research initiatives and expand its technological capabilities.

Pipeline Development

While specific pipeline candidates and clinical trial stages are not publicly disclosed, Knowledge Palette's focus on phenotypic drug discovery and cell manufacturing optimization suggests active development in these areas. The company collaborates with partners to accelerate the development of new medicines and improve cell manufacturing processes.

Technological Platform and Innovation

Knowledge Palette's proprietary technologies include:

• Quartz-Seq2: A single-cell transcriptome analysis technology recognized for its accuracy in the Human Cell Atlas project.

• High-Throughput Bulk Transcriptome Technology: Capable of analyzing a large variety of bulk samples simultaneously at reduced costs.

These platforms enable comprehensive analysis of gene expression, facilitating advancements in drug discovery and regenerative medicine.

Leadership Team

• Hiroki Danno, Ph.D.: Co-Founder, Co-Chief Executive Officer, and Representative Director.

• Masakazu Fukuda, Ph.D.: Co-Founder, Co-Chief Executive Officer, and Chief Technology Officer.

Both leaders bring extensive expertise in biotechnology and have been instrumental in steering the company's strategic direction and technological innovations.

Leadership Changes

As of October 1, 2023, Hiroki Danno serves as the Representative Director & CEO, underscoring the company's commitment to strong leadership.

Competitor Profile

Market Insights and Dynamics

The biotechnology sector, particularly in drug discovery and regenerative medicine, is experiencing significant growth. Advances in genomic analysis and personalized medicine are driving innovation, with companies leveraging cutting-edge technologies to address unmet medical needs.

Competitor Analysis

Key competitors include:

• 9xchange: An Israeli molecule marketplace facilitating the exchange of untapped assets through a curated system.

• 490 Biotech, Inc.: Develops light-emitting human cell lines for biological event reporting.

• Genentech: A U.S.-based biotechnology company dedicated to discovering and developing medicines for serious diseases.

These companies focus on various aspects of biotechnology, from drug development to innovative therapeutic solutions.

Strategic Collaborations and Partnerships

Knowledge Palette has established significant collaborations:

• Zeon Corporation: Participated in the Series B funding round, providing financial support for research and development.

• Celaid Therapeutics: Entered into a collaborative research contract to analyze cord blood samples using single-cell transcriptome technology.

• CiRA Foundation: Collaborated to study characteristics of iPS cells and derived differentiated cells.

• Axcelead Drug Discovery Partners: Engaged in research on gene expression analysis concerning drug-resistant cancer.

These partnerships enhance Knowledge Palette's research capabilities and market position.

Operational Insights

Strategically, Knowledge Palette differentiates itself through its proprietary technologies and collaborative approach. By focusing on phenotypic drug discovery and cell manufacturing optimization, the company addresses critical challenges in the biotechnology sector, positioning itself as a leader in innovative medical solutions.

Strategic Opportunities and Future Directions

Looking ahead, Knowledge Palette aims to:

• Expand its technological platforms to cover a broader range of therapeutic areas.

• Strengthen existing partnerships and establish new collaborations to accelerate research and development.

• Explore opportunities in personalized medicine and regenerative therapies to meet evolving healthcare needs.

Contact Information

For more information, visit Knowledge Palette's official website.

Note: Specific contact details such as address, phone number, and email are not provided in this profile.